Despite a growing knowledge about the biological diversity of papillomaviruses (PV), only little is known about non-human PV in general and about PV mice models in particular. We cloned and sequenced the complete genomes of two novel PV types from the Norway rat (Rattus norvegicus; RnPV2) and the wood mouse (Apodemus sylvaticus; AsPV1) as well as a novel variant of the recently described MmuPV1 (originally designated as MusPV) from a house mouse (Mus musculus; MmuPV1 variant). In addition, we conducted phylogenetic analyses using a systematically representative set of 79 PV types, including the novel sequences. As inferred from concatenated amino acid sequences of six proteins, MmuPV1 variant and AsPV1 nested within the Beta+Xi-PV super taxon as members of the Pi-PV. RnPV2 is a member of the Iota-PV that has a distant phylogenetic position from Pi-PV. The phylogenetic results support a complex scenario of PV diversification driven by different evolutionary forces including co-divergence with hosts and adaptive radiations to new environments. PV types particularly isolated from mice and rats are the basis for new animal models, which are valuable to study PV induced tumors and new treatment options.
References
[1]
zur Hausen H (2009) Papillomaviruses in the causation of human cancers - a brief historical account. Virology 384: 260–265.
[2]
Dyson N, Howley PM, Muenger K, Harlow E (1989) The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243: 934–937.
[3]
Nomine Y, Masson M, Charbonnier S, Zanier K, Ristriani T, et al. (2006) Structural and functional analysis of E6 oncoprotein: insights in the molecular pathways of human papillomavirus-mediated pathogenesis. Mol Cell 21: 665–678.
[4]
zur Hausen H (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2: 342–350.
[5]
Nindl I, Gottschling M, Stockfleth E (2007) Human papillomaviruses and non-melanoma skin cancer: Basic virology and clinical manifestations. Dis Markers 23: 247–259.
[6]
Iftner T, Elbel M, Schopp B, Hiller T, Loizou JI, et al. (2002) Interference of papillomavirus E6 protein with single-strand break repair by interaction with XRCC1. EMBO J 21: 4741–4748.
[7]
Giampieri S, Storey A (2004) Repair of UV-induced thymine dimers is compromised in cells expressing the E6 protein from human papillomaviruses types 5 and 18. Br J Cancer 90: 2203–2209.
[8]
Jackson S, Storey A (2000) E6 proteins from diverse cutaneous HPV types inhibit apoptosis in response to UV damage. Oncogene 19: 592–598.
[9]
Underbrink MP, Howie HL, Bedard KM, Koop JI, Galloway DA (2008) E6 proteins from multiple human betapapillomavirus types degrade Bak and protect keratinocytes from apoptosis after UVB irradiation. J Virol 82: 10408–10417.
[10]
Muschik D, Braspenning-Wesch I, Stockfleth E, Rosl F, Hofmann TG, et al. (2011) Cutaneous HPV23 E6 prevents p53 phosphorylation through interaction with HIPK2. Plos One 6: e27655.
[11]
Bernard HU, Burk RD, Chen Z, van Doorslaer K, zur Hausen H, et al. (2010) Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 401: 70–79.
[12]
Narechania A, Chen Z, DeSalle R, Burk RD (2005) Phylogenetic incongruence among oncogenic genital alpha human papillomaviruses. J Virol 79: 15503–15510.
[13]
Rector A, Lemey P, Tachezy R, Mostmans S, Ghim SJ, et al. (2007) Ancient papillomavirus-host co-speciation in Felidae. Genome Biol 8: R57.
[14]
Gottschling M, Stamatakis A, Nindl I, Stockfleth E, Alonso A, et al. (2007) Multiple evolutionary mechanisms drive papillomavirus diversification. Mol Biol Evol 24: 1242–1258.
[15]
Iwasaki T, Maeda H, Kameyama Y, Moriyama M, Kanai S, et al. (1997) Presence of a novel hamster oral papillomavirus in dysplastic lesions of hamster lingual mucosa induced by application of dimethylbenzanthracene and excisional wounding: molecular cloning and complete nucleotide sequence. J Gen Virol 78: 1087–1093.
[16]
Muller H, Gissmann L (1978) Mastomys natalensis papilloma virus (MnPV), the causative agent of epithelial proliferations: characterization of the virus particle. J Gen Virol 41: 315–323.
[17]
Tan CH, Tachezy R, van Ranst M, Chan SY, Bernard HU, et al. (1994) The Mastomys natalensis papillomavirus: nucleotide sequence, genome organization, and phylogenetic relationship of a rodent papillomavirus involved in tumorigenesis of cutaneous epithelia. Virology 198: 534–541.
[18]
Nafz J, Schafer K, Chen SF, Bravo IG, Ibberson M, et al. (2008) A novel rodent papillomavirus isolated from anogenital lesions in its natural host. Virology 374: 186–197.
[19]
O’Banion MK, Reichmann ME, Sundberg JP (1988) Cloning and characterization of a papillomavirus associated with papillomas and carcinomas in the European harvest mouse (Micromys minutus). J Virol 62: 226–233.
[20]
van Doorslaer K, Rector A, Jenson AB, Sundberg JP, van Rans M, et al. (2007) Complete genomic characterization of a murine papillomavirus isolated from papillomatous lesions of a European harvest mouse (Micromys minutus). J Gen Virol 88: 1484–1488.
[21]
Rector A, Tachezy R, van Doorslaer K, MacNamara T, Burk RD, et al. (2005) Isolation and cloning of a papillomavirus from a North American porcupine by using multiply primed rolling-circle amplification: the Erethizon dorsatum papillomavirus type 1. Virology 331: 449–456.
[22]
Schulz E, Gottschling M, Wibbelt G, Stockfleth E, Nindl I (2009) Isolation and genomic characterization of the first Norway rat (Rattus norvegicus) papillomavirus and its phylogenetic position within Pipapillomavirus, primarily infecting rodents. J Gen Virol 90: 2609–2614.
[23]
Joh J, Jenson AB, King W, Proctor M, Ingle A, et al. (2011) Genomic analysis of the first laboratory-mouse papillomavirus. J Gen Virol 92: 692–698.
[24]
Ingle A, Ghim S, Joh J, Chepkoech I, Bennett JA, et al. (2011) Novel laboratory mouse papillomavirus (MusPV) infection. Vet Pathol 48: 500–505.
[25]
Nafz J, Kohler A, Ohnesorge M, Nindl I, Stockfleth E, et al. (2007) Persistence of Mastomys natalensis papillomavirus in multiple organs identifies novel targets for infection. J Gen Virol 88: 2670–2678.
[26]
Garcia-Vallve S, Alonso A, Bravo IG (2005) Papillomaviruses: different genes have different histories. Trends Microbiol 13: 514–521.
[27]
Jackson A (2005) The effect of paralogous lineages on the application of reconciliation analysis by cophylogeny mapping. Syst Biol 54: 127–145.
[28]
Gottschling M, Goker M, Stamatakis A, Bininda-Emonds OR, Nindl I, et al. (2011) Quantifying the phylodynamic forces driving papillomavirus evolution. Mol Biol Evol 28: 2101–2113.
[29]
Rowe KC, Reno ML, Richmond DM, Adkins RM, Steppan SJ (2008) Pliocene colonization and adaptive radiations in Australia and New Guinea (Sahul): multilocus systematics of the old endemic rodents (Muroidea: Murinae). Mol Phylogenet Evol 47: 84–101.
[30]
Kohler A, Gottschling M, Forster J, Rowert-Huber J, Stockfleth E, et al. (2010) Genomic characterization of a novel human papillomavirus (HPV-117) with a high viral load in a persisting wart. Virology 399: 129–133.
[31]
Chong T, Chan WK, Bernard HU (1990) Transcriptional activation of human papillomavirus 16 by nuclear factor I, AP1, steroid receptors and a possibly novel transcription factor, PVF: a model for the composition of genital papillomavirus enhancers. Nucleic Acids Res 18: 465–470.
[32]
Gloss B, Bernard HU (1990) The E6/E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence-aberrant Sp1 distal element. J Virol 64: 5577–5584.
[33]
O’Connor M, Bernard HU (1995) Oct-1 activates the epithelial-specific enhancer of human papillomavirus type 16 via a synergistic interaction with NFI at a conserved composite regulatory element. Virology 207: 77–88.
[34]
Bernard HU (1990) Controls in the papillomavirus life cycle. FEMS Microbiol Immunol 2: 201–205.
[35]
Ensser A, Pfister H (1990) Epidermodysplasia verruciformis associated human papillomaviruses present a subgenus-specific organization of the regulatory genome region. Nucleic Acids Res 18: 3919–3922.
[36]
Tomaic V, Gardiol D, Massimi P, Ozbun M, Myers M, et al. (2009) Human and primate tumour viruses use PDZ binding as an evolutionarily conserved mechanism of targeting cell polarity regulators. Oncogene 28: 1–8.
[37]
Gottschling M, Wibbelt G, Wittstatt U, Stockfleth E, Nindl I (2008) Novel papillomavirus isolates from Erinaceus europaeus (Erinaceidae, Insectivora) and the Cervidae (Artiodactyla), Cervus timorensis and Pudu puda, and phylogenetic analysis of partial sequence data. Virus Genes 36: 281–287.
[38]
Schulz E, Gottschling M, Bravo IG, Wittstatt U, Stockfleth E, et al. (2009) Genomic characterization of the first insectivoran papillomavirus reveals an unusually long, second non-coding region and indicates a close relationship to Betapapillomavirus. J Gen Virol 90: 626–633.
[39]
Forslund O, Antonsson A, Nordin P, Stenquist B, Hansson BG (1999) A broad range of human papillomavirus types detected with a general PCR method suitable for analysis of cutaneous tumours and normal skin. J Gen Virol 80: 2437–2443.
[40]
Antonsson A, Hansson BG (2002) Healthy skin of many animal species harbors papillomaviruses which are closely related to their human counterparts. J Virol 76: 12537–12542.
[41]
Iftner T, Villa LL (2003) Chapter 12: Human papillomavirus technologies. J Natl Cancer Inst Monogr 31: 80–88.
[42]
Gasteiger E, Hoogland C, Gattiker A, Duvaud S, Wilkens MR, et al.. (2005) The Proteomic Protocols. Humana Press. 607 p.
[43]
Katoh K, Toh H (2008) Recent developments in the MAFFT multiple sequence alignment program. Brief Bioinform 9: 286–298.
